Skip to main navigation Skip to search Skip to main content

d-Serine, the Shape-Shifting NMDA Receptor Co-agonist

Joseph T. Coyle, Darrick Balu, Herman Wolosker

Research output: Contribution to journalReview articlepeer-review

Abstract

Shape-shifting, a phenomenon wide-spread in folklore, refers to the ability to physically change from one identity to another, typically from an innocuous entity to a destructive one. The amino acid d-serine over the last 25 years has “shape-shifted” into several identities: a purported glial transmitter activating N-methyl-d-aspartate receptors (NMDARs), a co-transmitter concentrated in excitatory glutamatergic neurons, an autocrine that is released at dendritic spines to prime their post-synaptic NMDARs for an instantaneous response to glutamate and an excitotoxic moiety released from inflammatory (A1) astrocytes. This article will review evidence in support of these scenarios and the artifacts that misled investigators of the true identity of d-serine.

Original languageEnglish
Pages (from-to)1344-1353
Number of pages10
JournalNeurochemical Research
Volume45
Issue number6
DOIs
StatePublished - 18 Mar 2020

Keywords

  • Astrocytes
  • Excitotoxicity
  • Glutamic acid
  • Serine racemase
  • d-Serine
  • γ-Amino-butyric acid (GABA)

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'd-Serine, the Shape-Shifting NMDA Receptor Co-agonist'. Together they form a unique fingerprint.

Cite this